Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases
about
Guidance for the treatment of deep vein thrombosis and pulmonary embolismCLINICAL PRACTICE. Polycystic Ovary Syndrome.Drospirenone-containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies.Life-Threatening Contraceptive-Related Pulmonary Embolism in a 14-Year-Old Girl with Hereditary Thrombophilia.Targets to treat androgen excess in polycystic ovary syndrome.Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.Medication safety research by observational study design.Oral Contraceptives Use and Liver Cancer Risk: A Dose-Response Meta-Analysis of Observational Studies.Clotting factor changes during the first cycle of oral contraceptive use.Oxidative Stress in Female Athletes Using Combined Oral Contraceptives."A magical little pill that will relieve you of your womanly issues": What young women say about menstrual suppression.Venous thromboembolism in adults screened for sickle cell trait: a population-based cohort study with nested case-control analysisFirst venous thromboembolism and hormonal contraceptives in young French women.Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.Recurrence risk of venous thromboembolism and hormone use in women from England: a cohort study using clinical practice research datalink.Influence of hormonal contraceptives and the occurrence of stroke: integrative review.Endogenous thrombin potential changes during the first cycle of oral contraceptive use.Variation in the risk of venous thromboembolism following colectomy.Low-dose second-generation oral contraceptives are associated with the lowest increased risk of cardiovascular adverse effects.Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence.Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.Risk prediction of developing venous thrombosis in combined oral contraceptive users.Identification of Genetic Interaction with Risk Factors Using a Time-To-Event Model.Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome.A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.Superior Mesenteric Vein Thrombosis in a Patient on Oral Contraceptive Pills.Atherothrombotic non-ST segment elevation myocardial infarction in a 42-year-old white female with no known cardiovascular risk factors.Combined Hormonal Contraceptives and First Venous Thrombosis in Young French Women: Impact of Thrombotic Family History.Risks of thromboembolism associated with hormone contraceptives in Japanese compared with Western women.Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database.Recent developments have made female permanent contraception an increasingly attractive option, and pregnant women in particular ought to be counselled about it.
P2860
Q28078989-E62F5FAC-DD93-4BB4-97A7-A20BC8058E4DQ29248890-B16594D6-395A-4DE4-A5EB-BA59B76CA0E8Q30235365-1AACD29C-5BA6-444D-A9A8-06F2C18E746BQ33166310-A0892057-87F0-4619-B4B9-AA372730B13BQ35835501-72C38700-BC4C-4BF1-9F53-070B23290003Q36887503-DADE9484-B756-4672-B875-DA7C1E1184ACQ37009536-54A1D2BC-CE23-4325-9D16-25A0BB95A0FAQ37176118-00C3496B-A514-4752-8E13-AB79C74C60BFQ37216764-B68CAE99-21AC-4D02-AC31-7952B950E0C5Q37273236-448DD8CA-9C9D-41EC-8C2A-0DA589E9018FQ37440013-D35B3779-F270-460F-B17E-E1894422980DQ37728480-A95E5B7E-EAE8-4E56-86F9-1D19155FE7A6Q38611491-555A1024-9352-420A-82FA-24AB99E99ED2Q38819411-F93039F1-15C3-4D2B-B6C3-EE6D64B52E1CQ38851182-1BA4CDA3-9A87-4EEA-B5A5-16FD957B7DE8Q38851530-E4BFE308-A59A-4118-9787-E986E408FEC3Q39341158-0AE0926D-7225-4833-B895-1040D4E2157DQ40380754-3AC45187-0625-4373-B7B2-BD464393FE7CQ40521321-BE57A3B7-2378-411E-B93A-9A64E24DA6BEQ40571140-39F7D4AC-F265-4348-B504-1F4C8A9B7ACFQ40616407-361A5506-40ED-4E1F-890B-7E9E10A22105Q41090535-04D28CE9-4E4B-4AF7-B543-8E91232F40A0Q41153519-16B27EDD-4B48-48AF-8DD2-EDBC6EFEC138Q47122227-E2DA8EDD-C734-4079-A954-0BB1C7A0088BQ47137256-6757392F-80A0-4D08-89B4-847B161774F5Q48517068-C3D9AAFE-C761-49A5-AE07-68EADCE3EFB6Q49264946-50F74D5F-D00C-436C-81F3-B6CF5BF0820EQ50882515-D981CA59-FBB6-402E-8CD2-5C9F01CF0C88Q51779337-54C50C3A-9E7A-4F0D-BA29-4FE0E5A0C3B6Q51827826-0C7C9983-DDB0-40E2-A35C-2EE8CF7D65BAQ55125188-D4ADDB0A-F13E-42BF-B04C-D2FDE006CE10Q55258013-81990597-4269-4D1B-AA9A-391747A9776A
P2860
Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Use of combined oral contracep ...... e QResearch and CPRD databases
@ast
Use of combined oral contracep ...... e QResearch and CPRD databases
@en
type
label
Use of combined oral contracep ...... e QResearch and CPRD databases
@ast
Use of combined oral contracep ...... e QResearch and CPRD databases
@en
prefLabel
Use of combined oral contracep ...... e QResearch and CPRD databases
@ast
Use of combined oral contracep ...... e QResearch and CPRD databases
@en
P2860
P356
P1433
P1476
Use of combined oral contracep ...... e QResearch and CPRD databases
@en
P2093
Yana Vinogradova
P2860
P356
10.1136/BMJ.H2135
P407
P577
2015-05-26T00:00:00Z